PATENT CLAIM ANALYSIS

Application Number: 15908013
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "452000"]

Abstract:
Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.

Claim (Index 1):
An immediate release abuse deterrent oral tablet comprising:\n i. two types of core shell particles, each type comprising a core, the core comprising a first gelling polymer, wherein:\n a. a first type of core-shell particles that comprise an amount of an active pharmaceutical ingredient (API) in a first layer surrounding the core, wherein said API is selected from ketamine, esketamine, and pharmaceutically acceptable salts thereof; and a second exterior layer that at least partially surrounds the first layer and comprises a pH sensitive polymer; and \n b. a second type of core-shell particles without an API-containing layer; and \n ii. a matrix comprising a pH adjuster and a second gelling polymer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.54286
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14539231', '14527215', '15423388', '15210760', '14132500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8727656447363421
- 35 USC 102 Novelty (BERT): 0.6945765508177749
- Combined Prediction Score: 0.8549467353444854
- Mean Citation Score: 708.105824
- Max Citation Score: 816.5063
- Similarity Product: 684.6450286545992

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test